We asked 2,100 clinicians what they really think of our surveys. Then we read every answer.

At the end of every ZoomRx survey there is one last question, and it has nothing to do with medicine. It asks how the survey was.

Most companies treat that box as decoration. We treat it as the most honest research we do. Since early 2025, more than 2,100 physicians, nurse practitioners and PAs have used it to leave over 5,000 comments. Some are one word. Some are in capital letters. One clinician wrote that a survey gave the feeling it was never going to end. Another said answering the questions had changed how they think about their own prescribing.

We read all of them. Here is what you told us, including the parts that were uncomfortable to hear.

First, the good news

More than half of the clinicians who left a comment rated their survey 9 or 10 out of 10. When we looked at what those people wrote, three things came up again and again.

It was easy. This was the single most common compliment, in about a third of the top-rated comments. Clear wording, sensible answer choices, no fighting with the screen between patients.

It was about your actual practice. Clinicians told us they liked being asked about the patients they really see and the decisions they really make. Several said the questions made them stop and reflect, which is not something people usually say about a survey.

It respected your intelligence. The best-rated surveys got to the point and did not ask the same thing five ways.

Now the part we did not enjoy reading

About one in four comments came with a rating of 6 or lower. The complaints were remarkably consistent.

"This took longer than you said." By far the most common grievance, in nearly three of every ten critical comments. A survey advertised at 15 minutes that takes 25 is not a small miss when it comes out of a lunch break.

"You already asked me that." Repetition was second. Rating the same attributes for product after product wears people down, and they told us so, sometimes vividly.

"I can't talk out loud in my office." Our voice-response and AI-interview surveys split the room. Some clinicians love being able to speak an answer instead of typing it. Others share a workspace and cannot.

None of this was a surprise in the abstract. Seeing it written thousands of times, by people whose time is worth a great deal, was different.

What we changed

Feedback is only worth collecting if something happens next. Over this period our team logged more than 1,000 follow-ups on individual comments. Four changes came directly out of them.

You are now paid by the minute. This is the big one. If a survey runs longer than advertised, that is our estimate failing, not your problem. New members are paid for the time a survey actually takes by default, so a 25-minute survey pays as a 25-minute survey.

We correct the estimate, not just the payment. When clinicians tell us a survey ran long, we raise the advertised length so the next person knows what they are agreeing to.

You are paid even when you do not qualify. Few things are more irritating than answering screening questions only to be told you are not a fit. At ZoomRx, time spent on a screener is compensated.

You choose how to answer. Speak or type. If you are in a shared office, type. If you are walking to the car, talk.

The things you did not have to ask for

A few parts of the experience have always been there, and they show up in the comments too.

Payouts are fast, through PayPal, Zelle or direct deposit, with no minimum balance to reach first.

And you can give your earnings away. Through our long-running partnership with Watsi, more than 2,200 ZoomRx members have donated part of their honoraria to fund medical care for 376 patients in 31 countries. Every dollar donated goes to the patient's treatment.

Why we are telling you this

We could have written a post saying our surveys are wonderful. A quarter of the comments say otherwise, and you would not have believed us anyway.

What we can say is this: when a clinician tells us something is wrong, a person reads it, and it often changes what the next clinician experiences. That is the standard we would like to be held to.

Join us, and tell us what you think

ZoomRx is a research community of physicians, nurse practitioners, PAs and other healthcare professionals whose views shape how new treatments are developed and communicated. Joining is free. You are paid for your time, by the minute, and your opinion is asked for one extra time at the end of every survey.

We will read that one too.